Eikon Therapeutics, Inc.

US$5.90As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EIKNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$319.6M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.53
10.68%
(1.30%)
Hold 5|9|7|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.12
0.13
0.13
27.43%
21.82%
31.50%
12.72%
Revenue$M
28.93
29.49
30.24
29.46
17.98%
17.15%
15.19%
7.01%
Peers (US$319.6M)
Cap (US$)
PE
323.5M
16.63x
318.5M
72.74x
Capital
TTM
5Y
10Y
Leveragex
1.608
1.349
1.118
EBIT/Intx
6.031
0.061
0.080
Own earn%
(31.62)
(8.70)
(20.88)
Sh yield%
57.24
44.28
52.14
Owners
Insiders/Inst%
10.71
24.02
Short interest%
0.81
SBC / revenue%
5.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
32–39
$1 testx
—
Incr. ROIC%
1